MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

NCT05931224 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2024-06-04

No results posted yet for this study

Summary

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Conditions

  • Essential Hypertension

Interventions

DRUG

D064, D702, placebo of D660

Experimental Group Subjects assigned to this group are treated with D064, D702, placebo of D660

DRUG

D660, placebo of D064, placebo of D702

Experimental Group Subjects assigned to this group are treated with D660, placebo of D064, placebo of D702

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Inho Chae, M.D, Ph.D · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2024-05-13
Completion
2024-05-13

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05931224 on ClinicalTrials.gov